209 related articles for article (PubMed ID: 35403824)
1. Landscape of the Peripheral Immune Response Induced by Local Microwave Ablation in Patients with Breast Cancer.
Zhou W; Yu M; Mao X; Pan H; Tang X; Wang J; Che N; Xie H; Ling L; Zhao Y; Liu X; Wang C; Zhang K; Qiu W; Ding Q; Wang S
Adv Sci (Weinh); 2022 Jun; 9(17):e2200033. PubMed ID: 35403824
[TBL] [Abstract][Full Text] [Related]
2. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer.
Zhou W; Yu M; Pan H; Qiu W; Wang H; Qian M; Che N; Zhang K; Mao X; Li L; Wang R; Xie H; Ling L; Zhao Y; Liu X; Wang C; Ding Q; Wang S
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795388
[TBL] [Abstract][Full Text] [Related]
3. Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A window-of-opportunity trial.
Pan H; Yu M; Tang X; Mao X; Liu M; Zhang K; Qian C; Wang J; Xie H; Qiu W; Ding Q; Wang S; Zhou W
Med; 2024 Apr; 5(4):291-310.e5. PubMed ID: 38417440
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model.
Zhu J; Yu M; Chen L; Kong P; Li L; Ma G; Ge H; Cui Y; Li Z; Pan H; Xie H; Zhou W; Wang S
Diagn Interv Imaging; 2018 Mar; 99(3):135-142. PubMed ID: 29398572
[TBL] [Abstract][Full Text] [Related]
5. Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells.
Yu M; Pan H; Che N; Li L; Wang C; Wang Y; Ma G; Qian M; Liu J; Zheng M; Xie H; Ling L; Zhao Y; Guan X; Ding Q; Zhou W; Wang S
Cell Mol Immunol; 2021 Sep; 18(9):2153-2164. PubMed ID: 32385362
[TBL] [Abstract][Full Text] [Related]
6. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer.
Li L; Wang W; Pan H; Ma G; Shi X; Xie H; Liu X; Ding Q; Zhou W; Wang S
J Transl Med; 2017 Jan; 15(1):23. PubMed ID: 28137271
[TBL] [Abstract][Full Text] [Related]
7. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice.
Duan X; Wang M; Han X; Ren J; Huang G; Ju S; Zhang Q
Cell Cycle; 2020 Dec; 19(24):3595-3607. PubMed ID: 33283623
[TBL] [Abstract][Full Text] [Related]
8. LAG3 blockade coordinates with microwave ablation to promote CD8
Shao D; Chen Y; Huang H; Liu Y; Chen J; Zhu D; Zheng X; Chen L; Jiang J
J Transl Med; 2022 Sep; 20(1):433. PubMed ID: 36180876
[TBL] [Abstract][Full Text] [Related]
9. Microwave ablation enhances the systemic immune response in patients with lung cancer.
Ma F; Lin Y; Ni Z; Wang S; Zhang M; Wang X; Zhang Z; Luo X; Miao X
Oncol Lett; 2024 Mar; 27(3):106. PubMed ID: 38298427
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation combined with anti-PD-1/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model.
Guo RQ; Peng JZ; Li YM; Li XG
Cell Cycle; 2023 Jan; 22(2):242-254. PubMed ID: 35980140
[TBL] [Abstract][Full Text] [Related]
11. Distinct immunoreactions after a primary tumor microwave ablation using different heating parameters in a VX2 tumor model.
Qian M; Lyu J; Da X; Zhu C; Wang G; Fang Y; Xu J
J Cancer Res Ther; 2023 Dec; 19(6):1620-1626. PubMed ID: 38156930
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis inhibition induces anti-tumor central memory CD8
Tang X; Mao X; Ling P; Yu M; Pan H; Wang J; Liu M; Pan H; Qiu W; Che N; Zhang K; Bao F; Peng H; Ding Q; Wang S; Zhou W
Nat Commun; 2024 May; 15(1):4665. PubMed ID: 38821965
[TBL] [Abstract][Full Text] [Related]
13. Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma.
Leuchte K; Staib E; Thelen M; Gödel P; Lechner A; Zentis P; Garcia-Marquez M; Waldschmidt D; Datta RR; Wahba R; Wybranski C; Zander T; Quaas A; Drebber U; Stippel DL; Bruns C; von Bergwelt-Baildon M; Wennhold K; Schlößer HA
Cancer Immunol Immunother; 2021 Apr; 70(4):893-907. PubMed ID: 33006650
[TBL] [Abstract][Full Text] [Related]
14. TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer.
Chen Y; Huang H; Li Y; Xiao W; Liu Y; Chen R; Zhu Y; Zheng X; Wu C; Chen L
Front Immunol; 2022; 13():832230. PubMed ID: 35320940
[TBL] [Abstract][Full Text] [Related]
15. Image and pathological changes after microwave ablation of breast cancer: a pilot study.
Zhou W; Jiang Y; Chen L; Ling L; Liang M; Pan H; Wang S; Ding Q; Liu X; Wang S
Eur J Radiol; 2014 Oct; 83(10):1771-7. PubMed ID: 25043496
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Study of the Impact of Microwave Ablation on the Dielectric Properties of Breast Tissue.
Neira LM; Mays RO; Sawicki JF; Schulman A; Harter J; Wilke LG; Behdad N; Van Veen BD; Hagness SC
Sensors (Basel); 2020 Oct; 20(19):. PubMed ID: 33036268
[TBL] [Abstract][Full Text] [Related]
17. Study on Changes in Immune Function After Microwave Ablation of Papillary Thyroid Microcarcinoma.
Wu T; Sui GQ; Teng DK; Luo Q; Wang H; Lin YQ
Cancer Manag Res; 2022; 14():2861-2868. PubMed ID: 36171864
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma.
Zhong X; Zhou Y; Cao Y; Ding J; Wang P; Luo Y; Liu H; Zhu Z; Jing X
Int J Hyperthermia; 2020; 37(1):1210-1218. PubMed ID: 33100037
[TBL] [Abstract][Full Text] [Related]
19. Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma.
Zhou Y; Xu X; Ding J; Jing X; Wang F; Wang Y; Wang P
J Cancer Res Ther; 2018 Jan; 14(1):40-45. PubMed ID: 29516957
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of ultrasound-guided percutaneous microwave ablation for benign breast lesions: a prospective study.
Zhang W; Jin ZQ; Baikpour M; Li JM; Zhang H; Liang T; Pan XM; He W
BMC Cancer; 2019 Apr; 19(1):345. PubMed ID: 30975107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
